Endothelial dysfunction serves as a central pathophysiological mechanism connecting various cardiovascular diseases, suggesting that targeting specific endothelial cell subtypes may yield new therapies.
Endothelial dysfunction is a central mechanism in cardiovascular disease, highlighting the potential for organ-specific therapies targeting endothelial cell subtypes.
Endothelial cells (ECs) are functionally heterogeneous, even in vascular beds within the same organ. As the key cell type lining the vascular lumen, ECs regulate vascular tone (control of blood vessel diameter), permeability of molecules, water, and ions across the vascular wall, vessel composition through cell-cell contacts, regulation of tissue redox status, and cytokine signaling. ECs are also influenced by mechanical stimuli such as blood flow. Many of these features can be analyzed in multi-cellular in vitro models that provide a controlled setting to investigate EC biology. Endothelial dysfunction (ED) has emerged as a central pathophysiological mechanism connecting different underlying cardiovascular diseases. Given that ECs are functionally heterogeneous, developing novel therapeutical approaches that target EC subtypes in specific tissues is anticipated to provide new diagnostic markers and therapeutic approaches for organ-specific treatment of cardiovascular disease.
Williams et al. (Sun,) conducted a review in Cardiovascular disease. Endothelial dysfunction serves as a central pathophysiological mechanism connecting various cardiovascular diseases, suggesting that targeting specific endothelial cell subtypes may yield new therapies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: